As an independent student newspaper and the paper of record for the city of Berkeley, the Daily Cal has been communicating important updates during this pandemic. Your support is essential to maintaining this coverage.
Disagreement persists between scientists at UC Berkeley and the Massachusetts Institute of Technology over the disputed patent rights to a gene-editing technology known as CRISPR-Cas9 potentially worth billions of dollars.
Read More…
On March 19, researchers led by campus professor of chemistry and molecular and cell biology Jennifer Doudna published an article in an online version of the journal Science advocating open discourse regarding the use of technology that can manipulate the human genome.
Read More…
UC Berkeley, partnering with UC San Francisco and the pharmaceutical industry, launched on Wednesday an initiative to research and develop gene-editing technologies for future medical care.
Read More…
Campus scientists and a cosmology team based at Lawrence Berkeley National Laboratory were recognized this week with the 2015 Breakthrough prize for their advances in the fields of life science and physics.
Read More…
Building on groundbreaking research in gene therapy released by UC Berkeley scientists, Bay Area researchers will work to push the boundaries of genetic engineering in a new collaboration between UC Berkeley and UC San Francisco.
Read More…
Jennifer Doudna, UC Berkeley professor of molecular and cell biology and chemistry was awarded the Lurie prize in Biomedical Sciences for her extensive research on RNA molecules Tuesday.
Read More…
